Advanced genetic testing solutions can identify conditions that can affect newborns and their long-term health or survival. These solutions can help labs in their efforts to drive early detection of genetic health risks in an efficient manner, enabling children to reach their full potential.
Applied Biosystems TaqMan SCID/SMA Plus Assay and TaqMan SCID/SMA Assay enable labs to analyze severe combined immunodeficiency syndrome (SCID) and spinal muscular atrophy (SMA) in newborns.
Shape the future of reproductive health by strengthening newborn screening capabilities of your lab.
For Research Use Only. Not for use in diagnostic procedures.